LADENBURG THALMANN FINANCIAL SERVICES INC. - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 25 filers reported holding CANCER GENETICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2019$3,000
-72.7%
29,763
-57.5%
0.00%
Q2 2019$11,000
+120.0%
70,057
+221.5%
0.00%
Q1 2019$5,000
+25.0%
21,794
+24.5%
0.00%
Q4 2018$4,000
-42.9%
17,500
+133.3%
0.00%
Q3 2018$7,0000.0%7,500
+66.7%
0.00%
Q2 2018$7,0000.0%4,5000.0%0.00%
Q1 2018$7,000
+40.0%
4,500
+80.0%
0.00%
Q4 2017$5,0002,5000.00%
Other shareholders
CANCER GENETICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 836,908$3,431,0003.54%
Fairbanks Capital Management, Inc. 233,170$956,0000.94%
DIKER MANAGEMENT LLC 63,315$260,0000.12%
EAM Investors, LLC 117,878$483,0000.08%
WEDBUSH SECURITIES INC 87,000$357,0000.05%
Acrospire Investment Management LLC 11,090$45,0000.04%
TWO SIGMA SECURITIES, LLC 16,053$66,0000.01%
THOMPSON DAVIS & CO., INC. 2,000$8,0000.01%
Manchester Capital Management LLC 9,000$37,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 40,158$165,0000.00%
View complete list of CANCER GENETICS INC shareholders